Results 191 to 200 of about 27,778 (225)

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Yilmaz Cakaloglu, Guido Gerken   +2 more
exaly  

Interferon Alfa-2b

2021
openaire   +1 more source

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Lancet, The, 2008
Mario Santinami, Alessandro A E Testori, Reinhard Dummer   +2 more
exaly  

Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa

New England Journal of Medicine, 2001
Amita K Manatunga, Charles B Nemeroff, Andrew H Miller   +2 more
exaly  

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

New England Journal of Medicine, 2007
Janice P Dutcher, Anil Kapoor, David F Mcdermott   +2 more
exaly  

INTERFERON ALFA

2014
openaire   +1 more source

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

Lancet, The, 2010
Patrick Royston
exaly  

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

Lancet, The, 2003
Tom Solomon, Nicholas J White
exaly  

Interferon alfa-2a for melanoma metastases

The Lancet, 2002
John M, Kirkwood, Joseph G, Ibrahim, Vernon K, Sondak, Marc S, Ernstoff, Merrick, Ross   +4 more
openaire   +2 more sources

Recombinant Interferon Alfa Therapy for Chronic Hepatitis C

New England Journal of Medicine, 1989
Zachary Goodman
exaly